NCT04344080View on ClinicalTrials.gov

Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

April 10, 2021

Study Completion Date

April 28, 2021

Conditions
COVID-19
Interventions
DEVICE

CytoSorb-Therapy

Additional use of Cytosorb-Adsorber in patients with COVID-19 and need for extracorporeal circulation (continuous renal replacement therapy or extracorporeal membrane oxygenation)

Trial Locations (1)

Unknown

University Medical Center Hamburg-Eppendorf, Hamburg

All Listed Sponsors
lead

Universitätsklinikum Hamburg-Eppendorf

OTHER

NCT04344080 - Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19 | Biotech Hunter | Biotech Hunter